A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) Clinical Practice Guidelines on Acute Kidney Injury: Part 2: Renal replacement therapy

Nephrology Dialysis Transplantation

Volumn 28, Issue 12, 2013, Pages 2940-2945

  Jörres, Achim ^a   John, Stefan ^b   Lewington, Andrew ^c   Ter Wee, Pieter M ^d   Vanholder, Raymond ^e   Van Biesen, Wim ^e   Tattersall, James ^c  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

^e GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Acute kidney injury; European renal best practice; Evidence based medicine; Guideline; Renal replacement therapy

Indexed keywords

ACUTE KIDNEY FAILURE; ARTIFICIAL KIDNEY; CATHETER INFECTION; CATHETER THROMBOSIS; CONTINUOUS HEMODIALYSIS; DIALYSATE; DIALYSIS CATHETER; DIALYSIS MEMBRANE; DOSE KIDNEY FUNCTION RELATION; DRUG DOSE; EUROPEAN RENAL BEST PRACTICE; FEMORAL VEIN; HEMODIALYSIS; HUMAN; INTENSIVE CARE UNIT; JUGULAR VEIN; KIDNEY DISEASE IMPROVING GLOBAL OUTCOMES CLINICAL PRACTICE GUIDELINE; META ANALYSIS (TOPIC); PERITONEAL DIALYSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENAL REPLACEMENT THERAPY; REVIEW; STENOSIS; SUBCLAVIAN VEIN; SYSTEMATIC REVIEW (TOPIC); TIME TO TREATMENT; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT PLANNING; UREA BLOOD LEVEL; VASCULAR ACCESS;

ACUTE KIDNEY INJURY; EUROPEAN RENAL BEST PRACTICE; EVIDENCE-BASED MEDICINE; GUIDELINE; RENAL REPLACEMENT THERAPY;

ACUTE KIDNEY INJURY; EVIDENCE-BASED MEDICINE; HUMANS; MEMBRANES, ARTIFICIAL; RENAL REPLACEMENT THERAPY; TIME FACTORS; VASCULAR ACCESS DEVICES;

EID: 84890098826     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gft297     Document Type: Review

References (39)

1. Coca SG, Singanamala S, Parikh CR. Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int 2012; 81: 442-448
2. Bucaloiu ID, Kirchner HL, Norfolk ER et al. Increased risk of death and de novo chronic kidney disease following reversible acute kidney injury. Kidney Int 2012; 81: 477-485
3. Chawla LS, Amdur RL, Amodeo S et al. The severity of acute kidney injury predicts progression to chronic kidney disease. Kidney Int 2011; 79: 1361-1369
4. Enia G, Panuccio V, Cutrupi S et al. Subclinical hypothyroidism is linked to micro-inflammation and predicts death in continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 2007; 22: 538-544
5. Zoccali C, Abramowicz D, Cannata-Andia JB et al. European best practice quo vadis? From European Best Practice Guidelines (EBPG) to European Renal Best Practice (ERBP). Nephrol Dial Transplant 2008; 23: 2162-2166. ERBP
6. Fliser D, Laville M, Covic A et al. A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) Clinical Practice Guidelines on Acute Kidney Injury: part 1: definitions, conservative management and contrast-induced nephropathy. Nephrol Dial Transplant 2012; 27: 4263-4272
7. Sever MS, Vanholder R. Recommendation for the management of crush victims in mass disasters. Nephrol Dial Transplant 2012; 27(Suppl. 1): i1-67
8. Clark E, Wald R, Walsh M et al. Timing of initiation of renal replacement therapy for acute kidney injury: a survey of nephrologists and intensivists in Canada. Nephrol Dial Transplant 2012; 59: 861-870
9. Bagshaw SM, Uchino S, Bellomo R et al. Timing of renal replacement therapy and clinical outcomes in critically ill patients with severe acute kidney injury. J Crit Care 2009; 24: 129-140
10. Karvellas CJ, Farhat MR, Sajjad I et al. A comparison of early versus late initiation of renal replacement therapy in critically ill patients with acute kidney injury: a systematic review and meta-analysis. Crit Care 2011; 15: R72
11. Bouman CS, Oudemans-Van Straaten HM, Tijssen JG et al. Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: a prospective, randomized trial. Crit Care Med 2002; 30: 2205-2211
12. Chou YH, Huang TM, Wu VC et al. Impact of timing of renal replacement therapy initiation on outcome of septic acute kidney injury. Crit Care 2011; 15: R134
13. Ostermann M, Dickie H, Barrett NA. Renal replacement therapy in critically ill patients with acute kidney injury-when to start. Nephrol Dial Transplant 2012; 27: 2242-2248
14. Vanholder R, Canaud B, Fluck R et al. Catheter-related blood stream infections (CRBSI): a European view. Nephrol Dial Transplant 2010; 25: 1753-1756
15. Eyer S, Brummitt C, Crossley K et al. Catheter-related sepsis: prospective, randomized study of three methods of long-term catheter maintenance. Crit Care Med 1990; 18: 1073-1079
16. Mermel LA, Allon M, Bouza E et al. Clinical practice guidelines for the diagnosis and management of intravascular catheterrelated infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 49: 1-45
17. Parienti JJ, Thirion M, Megarbane B et al. Femoral vs jugular venous catheterization and risk of nosocomial events in adults requiring acute renal replacement therapy: a randomized controlled trial. JAMA 2008; 299: 2413-2422
18. Dugue AE, Levesque SP, Fischer MO et al. Vascular access sites for acute renal replacement in intensive care units. Clin J Am Soc Nephrol 2012; 7: 70-77
19. Opatrny K, Jr. Clinical importance of biocompatibility and its effect on haemodialysis treatment. Nephrol Dial Transplant 2003; 18(Suppl. 5): v41-v44
20. Alonso A, Lau J, Jaber BL. Biocompatible hemodialysis membranes for acute renal failure. Cochrane Database Syst Rev 2008; 1: CD005283
21. Vinsonneau C, Camus C, Combes A et al. Continuous venovenous haemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: a multicentre randomised trial. Lancet 2006; 368: 379-385
22. Palevsky PM, Zhang JH, O'Connor TZ et al. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 2008; 359: 7-20
23. Lins RL, Elseviers MM, Van der Niepen P et al. Intermittent versus continuous renal replacement therapy for acute kidney injury patients admitted to the intensive care unit: results of a randomized clinical trial. Nephrol Dial Transplant 2009; 24: 512-518
24. Bagshaw SM, Berthiaume LR, Delaney A et al. Continuous versus intermittent renal replacement therapy for critically ill patients with acute kidney injury: a meta-analysis. Crit Care Med 2008; 36: 610-617
25. Pannu N, Klarenbach S, Wiebe N et al. Renal replacement therapy in patients with acute renal failure: a systematic review. JAMA 2008; 299: 793-805
26. Rabindranath K, Adams J, Macleod AM et al. Intermittent versus continuous renal replacement therapy for acute renal failure in adults. Cochrane Database Syst Rev 2007; 3: CD003773
27. Van Biesen W, Lameire N, Vanholder R. A tantalizing question: Ferrari or Rolls Royce? A meta-analysis on the ideal renal replacement modality for acute kidney injury at the intensive care unit. Crit Care Med 2008; 36: 649-650
28. Faulhaber-Walter R, Hafer C, Jahr N et al. The Hannover Dialysis Outcome study: comparison of standard versus intensified extended dialysis for treatment of patients with acute kidney injury in the intensive care unit. Nephrol Dial Transplant 2009; 24: 2179-2186
29. Eloot S, Van Biesen W, Dhondt A et al. Impact of hemodialysis duration on the removal of uremic retention solutes. Kidney Int 2008; 73: 765-770
30. Saudan P, Niederberger M, De Seigneux S et al. Adding a dialysis dose to continuous hemofiltration increases survival in patients with acute renal failure. Kidney Int 2006; 70: 1312-1317
31. Coresh J, Eknoyan G, Levey AS. Estimating the prevalence of low glomerular filtration rate requires attention to the creatinine assay calibration. J Am Soc Nephrol 2002; 13: 2811-2812. author reply 2812-6
32. Cheung AK, Yan G, Greene T et al. Seasonal variations in clinical and laboratory variables among chronic hemodialysis patients. J Am Soc Nephrol 2002; 13: 2345-2352
33. Ronco C, Bellomo R, Homel P et al. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 2000; 356: 26-30
34. Bellomo R, Cass A, Cole L et al. Intensity of continuous renalreplacement therapy in critically ill patients. N Engl J Med 2009; 361: 1627-1638
35. Tolwani AJ, Campbell RC, Stofan BS et al. Standard versus high-dose CVVHDF for ICU-related acute renal failure. J Am Soc Nephrol 2008; 19: 1233-1238
36. Vesconi S, Cruz DN, Fumagalli R et al. Delivered dose of renal replacement therapy and mortality in critically ill patients with acute kidney injury. Crit Care 2009; 13: R57
37. Demirjian S, Teo BW, Guzman JA et al. Hypophosphatemia during continuous hemodialysis is associated with prolonged respiratory failure in patients with acute kidney injury. Nephrol Dial Transplant 2011; 26: 3508-3514
38. Kielstein JT, Lorenzen J, Kaever V et al. Risk of underdosing of ampicillin/ sulbactam in patients with acute kidney injury undergoing extended daily dialysis-a single case. Nephrol Dial Transplant 2009; 24: 2283-2285
39. Kielstein JT, Eugbers C, Bode-Boeger SM et al. Dosing of daptomycin in intensive care unit patients with acute kidney injury undergoing extended dialysis-a pharmacokinetic study. Nephrol Dial Transplant 2010; 25: 1537-1541